​

Intuitive Surgical Stock (NASDAQ:ISRG)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$452.29

52W Range

$328.57 - $603.88

50D Avg

$397.20

200D Avg

$435.54

Market Cap

$159.55B

Avg Vol (3M)

$2.52M

Beta

1.46

Div Yield

-

ISRG Company Profile


Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

17,021

IPO Date

Jun 16, 2000

Website

ISRG Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Systems$2.47B$1.97B$1.68B
Services$1.57B$1.31B$1.17B
Instruments and Accessories$6.02B$5.08B$4.28B
Service--$1.17B

Fiscal year ends in Dec 25 | Currency in USD

ISRG Financial Summary


Dec 25Dec 24Dec 23
Revenue$10.06B$8.35B$7.12B
Operating Income$2.95B$2.35B$1.77B
Net Income$2.86B$2.32B$1.80B
EBITDA$3.31B$2.81B$2.17B
Basic EPS$8.00$6.54$5.12
Diluted EPS$7.87$6.42$5.03

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q3 26Oct 20, 26 | 4:30 PM
Q2 26Jul 16, 26 | 4:30 PM
Q1 26Apr 21, 26 | 4:30 PM

Peer Comparison


TickerCompany
SNNSmith & Nephew plc
MBOTMicrobot Medical Inc.
CNMDCONMED Corporation
SYKStryker Corporation